Custom Enzymes and Inhibitors
Pfaltz & Bauer Trypsin Inhibitor Soy Bean| 100MG | 9035-81-8
Trypsin Inhibitor Soy Bean| 100MG | 9035-81-8
Selleck Chemical LLC Emtricitabine 50mg 143491-57-0
Emtricitabine (FTC) is a new nucleoside agent that has activity against both human immunodeficiency virus (HIV) and hepatitis B virus. It is a reverse transcriptase inhibitor. Intracellular half-life is 39 h. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
Selleck Chemical LLC Barasertib (AZD1152-HQPA) S1147-25mg
Defosbarasertib (AZD1152-HQPA AZD2811 INH-34 Barasertib-HQPA) is a highly selective Aurora B inhibitor with IC50 of 0 37 nM in a cell-free assay 3700 fold more selective for Aurora B over Aurora A Phase 1
Selleck Chemical LLC Didanosine 50mg 69655-05-6
Didanosine is a reverse transcriptase inhibitor with an IC50 of 0.49 ?M. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
Sigma Organic Chemistry 4-Quinolinol | 1G | 611-36-9 | MFCD00006777
4-Quinolinol, 1G
About This Item:
Storage: room temp
EINECS Number: 210-268-2
Selleck Chemical LLC SU11274 2mg 658084-23-2 PKI-SU11274
SU11274 (PKI-SU11274) is a selective Met (c-Met) inhibitor with IC50 of 10 nM in cell-free assays, no effects on PGDFR?, EGFR or Tie2. SU11274 induces autophagy, apoptosis and cell cycle arrest. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
Selleck Chemical LLC XAV-939 10mM/1mL 284028-89-3 NVP-XAV939
XAV-939 (NVP-XAV939) selectively inhibits Wnt/?-catenin-mediated transcription through tankyrase1/2 inhibition with IC50 of 11 nM/4 nM in cell-free assays, regulates axin levels and does not affect CRE, NF-?B or TGF-?. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
Apexbio Technology LLC Caspase-8 inhibitor 210344-98-2. MFCD03490491
Caspase-8 inhibitor 210344-98-2. MFCD03490491
Apexbio Technology LLC PHA-793887 718630-59-2 5mg
PHA-793887 (CAS 718630-59-2) is a small-molecule inhibitor targeting cyclin-dependent kinases (CDKs) particularly CDK2 CDK5 and CDK7 exhibiting IC50 values of 8 nM 5 nM and 10 nM respectively CDKs regulate cell cycle progression and are frequently dysregulated in cancers PHA-793887 demonstrates pronounced antiproliferative activity against leukemia cell lines inducing cell-cycle arrest modulating phosphorylation of Rb and nucleophosmin and altering expression of cyclin E and cdc6 In leukemia xenograft and primary patient-derived models PHA-793887 reduces tumor burden supporting its application as a research tool in cancer biology
Apexbio Technology LLC An ATP-competitive, potent CDK1 inhibitor 872573-93-8. MFCD17392573
An ATP-competitive, potent CDK1 inhibitor 872573-93-8. MFCD17392573
Sigma Aldrich Fine Chemicals Biosciences TCID >=98% (HPLC) | 30675-13-9 | MFCD00239209 | 5MG
TCID >=98% (HPLC) | Purity: >=98% (HPLC) | Mol Wt: 283.92 | 30675-13-9 | MFCD00239209 | 5MG
Revvity Health Sciences Inc AlphaLISA Human EPO Detection Kit, Standard
AlphaLISA Human EPO Detection Kit, Standard
Abcam A 83-01, ALK4, 5 and 7 kinase inhibitor, 1MG
MW 421.5 Da, Purity >98%. Potent, selective TGF-β type I receptor ALK5, type I activin/nodal receptor ALK4 and type I nodal receptor ALK7 kinase inhibitor (IC₅₀ values are 12, 45 and 7.5 nM for ALK5, ALK4 and ALK7 respectively). TGF-β1 inhibitor. Inhibits TGF-β1-dependent α-SMA and collagen type I induction. Active in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Enzo Life Sciences Z-AAD-CMK (1mg)
Irreversible, cell-permeable inhibitor of granzyme B (ID50=0.3 µM). Does not inhibit granzyme A. Inhibition of granzyme B with Z-AAD-CMK prevented caspase-3 activation in T cells. Alternative name: Granzyme B inhibitor. Purity: ≥95% (HPLC). Formulation: Lyophilized. Solubility: Soluble in DMSO (25mg/ml), 100% ethanol (25mg/ml) or water (20mg/ml). Long Term Storage: -20°C.